欧洲 · 通讯社与实时数据 · Reuters Breakingviews
GSK is two shots away from clean bill of health
One of Europe’s most cheaply valued drugmakers, the £75 bln group run by Luke Miels is turning a corner. Fears over expiring patents are easing thanks to a booming oncology…
在 Reuters Breakingviews 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.reuters.com)
